✦ LIBER ✦

Sensitivity of human multiple myelomas and myeloid leukemias to the proteasome inhibitor I

✍ Scribed by Servida, F; Soligo, D; Delia, D; Henderson, C; Brancolini, C; Lombardi, L; Deliliers, G Lambertenghi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I and II pharmacokinetic and pharm

✍ Yoshiaki Ogawa; Kensei Tobinai; Michinori Ogura; Kiyoshi Ando; Takahide Tsuchiya 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB

Sensitivity and gene expression profile

✍ Lars Petter Jordheim; Adriana Plesa; Michel Dreano; Emeline Cros-Perrial; Céline 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 613 KB

A new matrix metalloproteinase inhibitor

✍ Nakamura, Y; Sato, K; Wakimoto, N; Kimura, F; Okuyama, A; Motoyoshi, K 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 333 KB

Sensitivity of chronic myeloid leukemia

✍ Visani, G. ;Lemoli, R. M. ;Tosi, P. ;Verlicchi, F. ;Gamberi, B. ;Cenacchi, A. R. 📂 Article 📅 1990 🏛 Springer-Verlag ⚖ 449 KB

The peptide-semicarbazone S-2209, a repr

✍ Philipp Baumann; Karin Müller; Sonja Mandl-Weber; Johann Leban; Robert Doblhofer 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 352 KB

A phase I trial of continuous infusion o

✍ Jeffrey E. Lancet; Maria R. Baer; George E. Duran; Alan F. List; Robert Fielding 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 195 KB